Skip to main content
Top
Published in: Journal of Neurology 5/2014

01-05-2014 | Original Communication

Diagnostic profiles of patients with late-onset Creutzfeldt–Jakob disease differ from those of younger Creutzfeldt–Jakob patients: a historical cohort study using data from the German National Reference Center

Authors: André Karch, Lena Maria Raddatz, Claudia Ponto, Peter Hermann, David Summers, Inga Zerr

Published in: Journal of Neurology | Issue 5/2014

Login to get access

Abstract

In contrast to other neurodegenerative diseases, sporadic Creutzfeldt–Jakob disease (sCJD) is rarely diagnosed in patients older than 75 years. Data describing the characteristics of sCJD in the very old are rare and inconclusive. Therefore, a historical cohort study was designed to evaluate clinical, cerebrospinal fluid (CSF), electroencephalography (EEG), and magnetic resonance imaging (MRI) features of this group. Patients older than 75 years identified via the German surveillance program from 2001 to 2012 (n = 73) were compared to a random subsample of sCJD patients younger than 75 (n = 73) from the same time period using an historical cohort design. Older patients showed a faster disease progression represented by an earlier point of diagnosis and a shorter survival time (p < 0.001). In the early stages of disease, older patients presented slightly more often with dementia (p = 0.127) or dysarthria (p = 0.238), whereas disorders of the extrapyramidal (p = 0.056) and visual system (p = 0.015) were more common in the younger group. Atypical MRI profiles such as MRI lesions restricted to one hemisphere (p < 0.001) or cortical lesions only (p = 0.258) were found more frequently in patients older than 75 years, whereas typical cortical and basal ganglia hyperintensities were more common in the younger group (p = 0.001). We demonstrated for the first time that patients with late-onset sCJD differ from younger sCJD patients with respect to MRI profiles and initial clinical presentation, but not among CSF markers. Misclassification of Creutzfeldt–Jakob disease cases in patients older than 75 years seems likely due to atypical clinical and radiological presentation. This might contribute to lower sCJD incidence rates in this age group.
Literature
1.
go back to reference Kovacs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, Collins SJ, Boyd A, Giulivi A, Coulthart M, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretzschmar HA, de Pedro-Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118:166–174CrossRefPubMed Kovacs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, Collins SJ, Boyd A, Giulivi A, Coulthart M, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretzschmar HA, de Pedro-Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118:166–174CrossRefPubMed
2.
go back to reference Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P (2012) Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 11:618–628CrossRefPubMed Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P (2012) Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 11:618–628CrossRefPubMed
3.
go back to reference World Health Organization (1998) Report of a WHO consultation on global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies. World Health Organization, Geneva World Health Organization (1998) Report of a WHO consultation on global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies. World Health Organization, Geneva
4.
go back to reference Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt–Jakob disease. Brain J Neurol 132:2659–2668CrossRef Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt–Jakob disease. Brain J Neurol 132:2659–2668CrossRef
5.
go back to reference Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AA, Trojanowski JQ, Petersen RB, Gambetti P (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt–Jakob disease. Ann Neurol 39:767–778CrossRefPubMed Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AA, Trojanowski JQ, Petersen RB, Gambetti P (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt–Jakob disease. Ann Neurol 39:767–778CrossRefPubMed
6.
7.
go back to reference Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A (1998) Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 147:574–580CrossRefPubMed Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A (1998) Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 147:574–580CrossRefPubMed
8.
go back to reference Brandel JP, Salomon D, Hauw JJ, Haik S, Alperovitch A (2008) Creutzfeldt–Jakob disease in patients before and after 80 years of age. Psychologie neuropsychiatrie du vieillissement 6:219–224PubMed Brandel JP, Salomon D, Hauw JJ, Haik S, Alperovitch A (2008) Creutzfeldt–Jakob disease in patients before and after 80 years of age. Psychologie neuropsychiatrie du vieillissement 6:219–224PubMed
9.
go back to reference Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I (2007) Creutzfeldt–Jakob disease in Germany: a prospective 12-year surveillance. Brain J Neurol 130:1350–1359CrossRef Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I (2007) Creutzfeldt–Jakob disease in Germany: a prospective 12-year surveillance. Brain J Neurol 130:1350–1359CrossRef
10.
go back to reference Holman RC, Belay ED, Christensen KY, Maddox RA, Minino AM, Folkema AM, Haberling DL, Hammett TA, Kochanek KD, Sejvar JJ, Schonberger LB (2010) Human prion diseases in the United States. PLoS One 5:e8521PubMedCentralCrossRefPubMed Holman RC, Belay ED, Christensen KY, Maddox RA, Minino AM, Folkema AM, Haberling DL, Hammett TA, Kochanek KD, Sejvar JJ, Schonberger LB (2010) Human prion diseases in the United States. PLoS One 5:e8521PubMedCentralCrossRefPubMed
11.
12.
go back to reference Cousens SN, Zeidler M, Esmonde TF, De Silva R, Wilesmith JW, Smith PG, Will RG (1997) Sporadic Creutzfeldt–Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970–96. BMJ 315:389–395PubMedCentralCrossRefPubMed Cousens SN, Zeidler M, Esmonde TF, De Silva R, Wilesmith JW, Smith PG, Will RG (1997) Sporadic Creutzfeldt–Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970–96. BMJ 315:389–395PubMedCentralCrossRefPubMed
13.
go back to reference Van Everbroeck B, Michotte A, Sciot R, Godfraind C, Deprez M, Quoilin S, Martin JJ, Cras P (2006) Increased incidence of sporadic Creutzfeldt–Jakob disease in the age groups between 70 and 90 years in Belgium. Eur J Epidemiol 21:443–447CrossRefPubMed Van Everbroeck B, Michotte A, Sciot R, Godfraind C, Deprez M, Quoilin S, Martin JJ, Cras P (2006) Increased incidence of sporadic Creutzfeldt–Jakob disease in the age groups between 70 and 90 years in Belgium. Eur J Epidemiol 21:443–447CrossRefPubMed
14.
go back to reference Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 335:924–930CrossRefPubMed Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 335:924–930CrossRefPubMed
15.
go back to reference Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt–Jakob disease. Ann Neurol 43:32–40CrossRefPubMed Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt–Jakob disease. Ann Neurol 43:32–40CrossRefPubMed
16.
go back to reference Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P, Ciesielczyk B, Schulz-Schaeffer W, Kretzschmar HA, Poser S (2002) Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease. Neurology 58:192–197CrossRefPubMed Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P, Ciesielczyk B, Schulz-Schaeffer W, Kretzschmar HA, Poser S (2002) Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease. Neurology 58:192–197CrossRefPubMed
17.
go back to reference Meissner B, Kallenberg K, Sanchez-Juan P, Krasnianski A, Heinemann U, Varges D, Knauth M, Zerr I (2008) Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt–Jakob disease. AJNR 29:1519–1524CrossRefPubMed Meissner B, Kallenberg K, Sanchez-Juan P, Krasnianski A, Heinemann U, Varges D, Knauth M, Zerr I (2008) Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt–Jakob disease. AJNR 29:1519–1524CrossRefPubMed
Metadata
Title
Diagnostic profiles of patients with late-onset Creutzfeldt–Jakob disease differ from those of younger Creutzfeldt–Jakob patients: a historical cohort study using data from the German National Reference Center
Authors
André Karch
Lena Maria Raddatz
Claudia Ponto
Peter Hermann
David Summers
Inga Zerr
Publication date
01-05-2014
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 5/2014
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7283-1

Other articles of this Issue 5/2014

Journal of Neurology 5/2014 Go to the issue